Skip to main content
Drugwatch.com
  • High-Risk Drugs & Devices
    • Drugs
      • Zantac
        • Zantac Side Effects
      • Elmiron
        • Elmiron Side Effects
      • Belviq
        • Belviq Side Effects
      • Xeljanz
        • Xeljanz Side Effects
      • Taxotere
        • Taxotere Side Effects
      • Singulair
      • Proton Pump Inhibitors (PPIs)
        • Nexium
        • Prilosec
      • Talcum Powder
        • Talc & Mesothelioma
        • Talc & Ovarian Cancer
    • Devices
      • Juul and E-Cigarettes
        • JUUL and E-Cigarette Side Effects
      • Hip Replacement
        • Hip Replacement Complications
      • Hernia Mesh
        • Hernia Mesh Complications
      • Allergan Breast Implants
        • Allergan Breast Implant Recalls
      • IVC Filter
        • IVC Filter Complications
      • Transvaginal Mesh
        • Transvaginal Mesh Complications
      • Philips CPAP
        • Philips CPAP Recall
      • NuVasive MAGEC System
      • Exactech Replacements
  • Health Issues
    • Side Effects
    • Health Guides
      • Women
        • Pregnancy
        • Birth Control
      • Conditions
        • Cancer
        • Maculopathy
        • Sleep Apnea
        • Crohn’s Disease
      • Personal Health
        • Men
        • Children
        • Seniors
        • Mental Health
      • Consumer Resources
        • Drug Interactions
        • How to Obtain Medical Records
        • How to Read a Drug Label
        • Big Pharma
    • Patient Stories
    • Rachel Brummert, Patient advocate
      Latest Story
      Testing Positive for COVID-19: It Felt Like I Had a Compression Belt Around My Chest
    • Featured Articles
    • Covid-19 under microscopic view
      Featured Article
      COVID-19: A Consumer’s Guide to the Coronavirus
      April 6, 2020
  • Active Lawsuits
    • Lawsuits Directory
      • Prescription Drug Lawsuits
        • Zantac Lawsuit
        • Elmiron Lawsuits
        • Belviq Lawsuits
        • Xeljanz Lawsuits
        • Proton Pump Inhibitor Lawsuits
        • Singulair Lawsuits
        • Injectafer Lawsuits
      • Product Lawsuits
        • E-Cigarette Lawsuits
        • Paraquat Lawsuits
        • Baby Formula Lawsuits
        • Talcum Powder Lawsuits
      • Medical Device Lawsuits
        • Philips CPAP Lawsuits
        • Hernia Mesh Lawsuits
        • Exactech Replacement Lawsuits
        • Hip Replacement Lawsuits
        • Paragard Lawsuits
    • Injured by a prescription drug or defective medical device?
      Get a Free Case Review
  • Our Community
    • About Drugwatch
      • Our Team
        • Drugwatch Editorial Policy
        • Press Room
      • Our Trusted Legal Partners
        • Awards & Accreditations
        • Drugwatch FAQ
    • Our Expert Contributors
      • Jayne Conroy, Named Shareholder of Simmons Hanly Conroy
        Jayne Conroy, Esquire Trial Attorney and Pharmaceutical Litigation Expert
      • Carl V. Crawford, M.D.
        Carl V. Crawford, M.D. Gastroenterologist/Hepatologist
      • Dr. Gopal Badlani
        Gopal Badlani, M.D. Board-Certified Urologist
      • Trent B. Miracle, Attorney at Simmons Hanly Conroy
        Trent B. Miracle, Esquire Trial Attorney and Pharmaceutical Litigation Expert
    • News
    • an empty shopping basket sits on an empty shelf at the grocery store
      Latest News
      Navigating the Baby Formula Shortage
      May 18, 2022
    • Drugwatch Podcast
    • iQOS Vaping Device
      Latest Podcast
      Erika Sward of American Lung Association Reveals the Dangers of Vaping and IQOS
      August 31, 2020
SPEAK WITH AN EXPERT
Call Now (888) 645-1617 Who Am I Calling?
(888) 645-1617Call Now
click to open search box

ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

FDA News & Recalls

  • letter of resignation
    FDA Chief Gottlieb Resigns; Urged Faster Drug and Device Approvals
    U.S. Food and Drug Administration Commissioner Dr. Scott Gottlieb has announced he will resign in early April. Gottlieb is a medical doctor…
    Terry Turner
    Terry Turner March 21, 2019
  • government shutdown US capital building
    Government Shutdown Threatens Drug and Medical Device Approvals, Safety
    U.S. senators have demanded answers about the threat to drug and medical device safety and prospects for approving new drugs and devices during the…
    Terry Turner
    Terry Turner January 17, 2019
  • Man reaching for prescription pills
    More Blood Pressure Drugs Added to Valsartan Recall List
    Mylan and Teva Pharmaceuticals — two large generic drug manufacturers — expanded their U.S. valsartan recalls in November because of contamination with a…
    Michelle Llamas, Senior Content Writer
    Michelle Llamas December 5, 2018
  • Blood pressure meter and white pills
    FDA Finds Second Cancer-Causing Impurity in Some Valsartan Heart Drugs
    The U.S. Food and Drug Administration has found a second cancer-causing impurity in three lots of the popular blood pressure medicine valsartan. The…
    Terry Turner
    Terry Turner September 14, 2018
  • Prescription pills
    2018 FDA Updates on Valsartan, FAQS
    Federal drug regulators continue to investigate how a cancer-causing chemical contaminated some blood-pressure medicine taken by millions of Americans called valsartan. The U.S. Food…
    Michelle Llamas, Senior Content Writer
    Michelle Llamas September 6, 2018
  • Man looking at a pill bottle
    Flesh-Eating Genital Disease Linked to SGLT2 Inhibitor Diabetes Drugs
    The U.S. Food and Drug Administration issued a warning that popular Type 2 diabetes drugs may be linked to a flesh-eating bacterial infection of…
    Michelle Llamas, Senior Content Writer
    Michelle Llamas August 30, 2018
Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 18
Next
Drugwatch Archives

Looking for an older news story? Search the Drugwatch archives for any of our published news posts by month and category.

Who Am I Calling?

Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.

Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(888) 645-1617
Subscribe to Our Newsletter

Join our newsletter to stay up to date on dangerous drugs and devices, keep up on lawsuit and settlement news, learn about FDA recalls, and more.

Sign Up NowConnect with Drugwatch on Twitter
Navigate
  • FAQ
  • Lawsuits
  • FDA
  • News
  • Drugs
  • Health Info
  • Devices
  • Drugwatch Podcast
  • Side Effects
  • Beyond Side Effects
Drugwatch.com

Keep people safe from potentially harmful drugs, medical devices and procedures by informing them of medical conditions, severe side effects and ways to take action.

More About Us
  • (888) 645-1617 Who Am I Calling?
  • Connect with Drugwatch on Facebook
  • Connect with Drugwatch on Twitter
  • Connect with Drugwatch on Youtube
  • Contact Drugwatch by Email
  • Click for the BBB Business Review of Drugwatch.com, LLC
  • AMWA Member Logo
  • APHA Logo
  • This website is certified by Health On the Net Foundation. Click to verify.

    This site complies with the HONcode standard for trustworthy health information: Verify here.

Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801

The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

Drugwatch.com partners with law firms. This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.

© 2022 Drugwatch.com Privacy Policy /

California Consumer Privacy Act (CCPA) Inquiries

Drugwatch.com doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.

Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.

If you would like to speak with a Drugwatch representative, please call 888-645-1617